Fabio Cominelli MD PhD | University Hospitals

University Hospitals Digestive Health Institute Research Initiatives Update

Innovations in Digestive Health | Spring 2024

4/1/2024 By Fabio Cominelli, MD, PhD and UH

Research Discoveries Boost Personalized Treatment for IBD

Fabio Cominelli, MD discusses how his team of researchers discovered the specific blockade of interleukin-18 can reduce disease severity in colitis and new personalized therapies to put IBD in permanent remission.

3/16/2023 By Daniel Simon, MD and Fabio Cominelli, MD, PhD

Does the Microbiome Hold the Key to Treating Inflammatory Bowel Disease?

Gut instincts - Innovations in Digestive Health | Winter 2020

3/11/2020 By Fabio Cominelli, MD, PhD and UH

Suppressing Inflammation in IBD Patients

UH Digestive Health Institute explores new IBD treatment using IL-1 targeted therapy UH Innovations in Digestive Health - Fall 2018 Fabio Cominelli, MD For 25 years, researchers have studied interleukin-1 (IL-1), a highly active proinflammatory...

10/29/2018 By Fabio Cominelli, MD, PhD

Investigating Treatments for Inflammatory Bowel Disease

UH Inflammatory Bowel Disease Center advances clinical research and therapies to treat Crohn's disease and ulcerative colitis UH Digestive Health Institute - Winter 2018 Fabio Cominelli, MD, PhD Maneesh Dave, MD, MPH Jeffrey Katz, MD A...

1/4/2018 By Fabio Cominelli, MD, PhD, Maneesh Dave, MD, MPH, and Jeffrey Katz, MD

Excellence in Leading Edge Crohn's Disease Research

UH Digestive Disease Institute | Janaury 2017

1/3/2017 By Fabio Cominelli, MD, PhD

UH Gastroenterologist Leading New NIH-Funded Digestive Diseases Research Core Center

Innovative care for Inflammatory and Metabolic Digestive Disease UH Digestive Health Institute - January 2016 Fabio Cominelli, MD, PhD Fabio Cominelli, MD, PhD, Chief Scientific Officer, UH Digestive Health Institute; Chief, Division of...

1/1/2016 By Fabio Cominelli, MD, PhD